These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9990448)

  • 1. Inhibition of transforming growth factor-beta 2 expression with phosphorothioate antisense oligonucleotides in U937 cells.
    Shen ZJ; Kim SK; Lee YS; Lee JW; Moon BJ
    Bioorg Med Chem Lett; 1999 Jan; 9(1):13-8. PubMed ID: 9990448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of transforming growth factor-beta2 expression in human osteoblast cells by antisense phosphorothioate oligonucleotides.
    Shen ZJ; Kim SK; Kwon OS; Lee YS; Moon BJ
    Eur J Biochem; 2001 Apr; 268(8):2331-7. PubMed ID: 11298751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.
    Kang H; Fisher MH; Xu D; Miyamoto YJ; Marchand A; Van Aerschot A; Herdewijn P; Juliano RL
    Nucleic Acids Res; 2004; 32(14):4411-9. PubMed ID: 15316104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
    Monia BP; Johnston JF; Geiger T; Muller M; Fabbro D
    Nat Med; 1996 Jun; 2(6):668-75. PubMed ID: 8640558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
    Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
    Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta-mediated regulation of human peripheral blood mononuclear cell proliferation as detected with phosphorothioate antisense oligodeoxynucleotides.
    Jachimczak P; Fabel-Schulte K; Hessdörfer B; Brysch W; Schlingensiepen KH; Blesch A; Bogdahn U
    Cell Immunol; 1995 Oct; 165(1):125-33. PubMed ID: 7671316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.
    Arima H; Takahashi M; Aramaki Y; Sakamoto T; Yuda K; Akiyama K; Goto T; Tsuchiya S
    Pharm Res; 1999 Aug; 16(8):1163-71. PubMed ID: 10468015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
    Hatta T; Takai K; Nakada S; Yokota T; Takaku H
    Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transforming growth factor-beta 1 alters the growth, anchor-dependent cell aggregation and integrin mRNA expression in human promonocytes: implications for endometriosis and peritoneal adhesion formation.
    Dou Q; Williams RS; Chegini N
    Mol Hum Reprod; 1997 May; 3(5):383-91. PubMed ID: 9239722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and evaluation of NGF antisense oligonucleotides: inhibition of NGF synthesis in transfected COS cells.
    Hallböök F; Sahlén A; Catsicas S
    Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):89-100. PubMed ID: 9149844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense transforming growth factor-beta 1 in wound healing.
    Chung HT; Choi BM; Jun CD; Park SD; Rim JS
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):257-61. PubMed ID: 9212921
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides.
    Hatzfeld J; Li ML; Brown EL; Sookdeo H; Levesque JP; O'Toole T; Gurney C; Clark SC; Hatzfeld A
    J Exp Med; 1991 Oct; 174(4):925-9. PubMed ID: 1717634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS.
    Peng Ho S; Livanov V; Zhang W; Li J; Lesher T
    Brain Res Mol Brain Res; 1998 Nov; 62(1):1-11. PubMed ID: 9795101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.
    Santiago FS; Atkins DG; Khachigian LM
    Am J Pathol; 1999 Sep; 155(3):897-905. PubMed ID: 10487847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity, uptake kinetics and efficacy of new transfection reagents: increase of oligonucleotide uptake.
    Axel DI; Spyridopoulos I; Riessen R; Runge H; Viebahn R; Karsch KR
    J Vasc Res; 2000; 37(4):221-34; discussion 303-4. PubMed ID: 10965222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes.
    Nestle FO; Mitra RS; Bennett CF; Chan H; Nickoloff BJ
    J Invest Dermatol; 1994 Oct; 103(4):569-75. PubMed ID: 7930684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
    Smetsers TF; van de Locht LT; Pennings AH; Wessels HM; de Witte TM; Mensink EJ
    Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.
    Monia BP; Sasmor H; Johnston JF; Freier SM; Lesnik EA; Muller M; Geiger T; Altmann KH; Moser H; Fabbro D
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15481-4. PubMed ID: 8986837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
    Saijo Y; Uchiyama B; Abe T; Satoh K; Nukiwa T
    Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.